For the Inventor, By the Inventor

Enter assignee name

Utrecht, Netherlands

Am-Pharma B.v.

USPTO Granted Patents = 9

% Expired Patents = 11.1

EPO Patents = 9

Trademarks = 1

Forward Citations = 36

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Willem Raaben (6 out of 6 patents)

Luigi Johannes Cornelius Jonk (6 out of 6 patents)

Erik Jan Van Den Berg (6 out of 6 patents)

4. Andrea Van Elsas (4 out of 19 patents)

5. José Luis Millán (4 out of 5 patents)

6. Markwin Paul Velders (2 out of 2 patents)

7. Roelof Peter Pickkers (2 out of 2 patents)

8. Stephen Edward Connor (1 out of 3 patents)

9. Abhinav Alok Shukla (1 out of 1 patent)

10. Heather Bethea Horne (1 out of 1 patent)

11. Susan Cook (1 out of 1 patent)

12. Timothy Martin Kelly (1 out of 3 patents)

13. Victoria Anne Dowling (1 out of 1 patent)

14. Mialy Fanjamalala Ramaroson (1 out of 1 patent)

15. Suzanne Heemskerk (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12534713 - CHIMERIC ALKALINE PHOSPHATASE-LIKE PROTEINS (2026-01-27),

2. 12178857 - Recombinant alkaline phosphatase for use in treating sepsis-associated acute kidney injury (2024-12-31),

3. 11746340 - Chimeric alkaline phosphatase-like proteins (2023-09-05),

4. 10822597 - Chimeric alkaline phosphatase-like proteins (2020-11-03),

5. 10570380 - Downstream processing of an alkaline phosphatase (2020-02-25),

6. 9926544 - Chimeric alkaline phosphatase-like proteins (2018-03-27),

7. 8586032 - Use of alkaline phosphatase in the treatment of reduced renal function (2013-11-19),

8. 8557545 - Modified phosphatases (2013-10-15),

9. 7060677 - Antimicrobial activity of the first cationic cluster of human lactoferrin (2006-06-13),

Am-Pharma B.V. is a biopharmaceutical company focused on the development of innovative therapeutics for the treatment of kidney diseases. Their lead product candidate, recAP (recombinant human Alkaline Phosphatase), is currently in Phase III clinical trials for the treatment of Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). Am-Pharma is committed to improving the lives of patients with kidney diseases through the development of novel and effective treatments.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

9 Patents

#16 in Utrecht

#680 in Netherlands

Utrecht, Netherlands

Am-Pharma B.v.

Forward Citations = 36

25 inventors:

Willem Raaben (6 out of 6 patents)

Luigi Johannes Cornelius Jonk (6 out of 6 patents)

Erik Jan Van Den Berg (6 out of 6 patents)

4. Andrea Van Elsas (4 out of 19 patents)

5. José Luis Millán (4 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…